Nasdaq Jumps 100 Points; Amazon Posts Upbeat Earnings
Portfolio Pulse from Lisa Levin
The Nasdaq Composite gained over 100 points, driven by strong earnings from Amazon. Amazon's Q3 revenue increased 13% YoY to $143.1 billion, beating estimates, and expects Q4 revenue between $160 billion and $167 billion. Other stocks that saw significant movement include Apollomics, BIO-key International, and SeaStar Medical Holding which saw increases, while Siyata Mobile, Medicenna Therapeutics, and TransCode Therapeutics saw decreases.
October 27, 2023 | 1:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Amazon reported stronger-than-expected Q3 results, with revenue increasing 13% YoY to $143.1 billion, beating estimates. The company expects Q4 revenue between $160 billion and $167 billion.
Amazon's strong Q3 results and positive Q4 outlook are likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Apollomics shares shot up 142% after announcing report of activity of vebreltinib in glioblastoma multiforme with PTPRZ-MET fusion.
The positive report on vebreltinib's activity in glioblastoma multiforme is likely to boost investor confidence in Apollomics, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
BIO-key International shares got a boost, shooting 62% up after the company said ALPI Portugal Lda. has deployed AuthControl Sentry company-wide for enhanced data access security.
The deployment of BIO-key's AuthControl Sentry by ALPI Portugal is likely to boost investor confidence in the company, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Medicenna Therapeutics shares were down 28% as the company announced Nasdaq delisting and cutback of management team.
The announcement of Nasdaq delisting and management team cutback is likely to negatively impact investor confidence in Medicenna Therapeutics, driving the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
TransCode Therapeutics shares fell 29% after the company announced a public offering of common stock.
The announcement of a public offering of common stock by TransCode Therapeutics is likely to dilute existing shares, driving the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Siyata Mobile shares dropped 51% as the company reported pricing of $1.6 million public offering of common shares.
The pricing of Siyata Mobile's public offering of common shares is likely to dilute existing shares, driving the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100